Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation Shang-Hung ChangYung-Hsin YehWei-Jan Chen Original Contribution 04 September 2017 Article: 58
Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction Nick J. R. BlackburnBranka VulesevicErik J. Suuronen Original Contribution 01 September 2017 Article: 57
Cardiac optogenetics: using light to monitor cardiac physiology Charlotte D. KoopmanWolfram H. ZimmermannTeun P. de Boer Review Open access 31 August 2017 Article: 56
Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction Xin XuPing ZhangYingjie Chen Original Contribution 17 August 2017 Article: 55
Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs Wennan LiXingjuan ChenAlexander G. Obukhov Original Contribution Open access 29 July 2017 Article: 54
Erratum to: Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting Teresa A. ZimmersYanlin JiangLeonidas G. Koniaris Erratum 18 July 2017 Article: 53
Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors Leonardo MacielDahienne F. de OliveiraJose Hamilton Matheus Nascimento Original Contribution 10 July 2017 Article: 52
Erratum to: Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillation Stefanie Meyer-RoxlauSimon LämmleAli El-Armouche Erratum 07 July 2017 Article: 51
Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics Laura Padrón-BartheFernando DomínguezEnrique Lara-Pezzi Review 07 July 2017 Article: 50
